Note that some links may require registration or subscription. Sen. Bill Cassidy, MD (R-La.), called for this week's planned meeting of the CDC's Advisory Committee on Immunization Practices (ACIP) to ...

Patrizia Cavazzoni, director of FDA’s Center for Drug Evaluation and Research, has announced her retirement from the agency. Editor's Note: This story has been updated to include a comment by Glenn ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Dr. George Tidmarsh doesn’t have an established track record ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and Research (CDER) in veteran biotech executive George Tidmarsh, M.D., Ph.D.

One surprising consequence of the coronavirus pandemic and its work-from-home zeitgeist? Biopharma companies have been compelled to rethink and perhaps even improve how they operate their businesses.

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has a new chief drug regulator, with industry veteran Dr Richard Pazdur taking the helm ...

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has published a new guidance agenda that outlines the guidance it plans to release this year, including both ...

After almost two years of anticipation, Janet Woodcock, director of the Center for Drug Evaluation and Research, has administration approval for organizational changes to bolster programs and policies ...

With negotiations underway for the next iterations of the US Food and Drug Administration’s (FDA) new and generic drug user fee programs, top officials from the Center for Drug Evaluation and Research ...

FDA’s Center for Drug Evaluation and Research released its report on new drugs approved in 2023. FDA’s Center for Drug Evaluation and Research (CDER) published its New Drug Therapy Approvals 2023 ...